Return to previous page

SLE705 - Biopharmaceuticals and Medical Devices

Unit details

Year2016 unit information
Enrolment modes:

Not offered from 2015

Credit point(s):1
Previously coded as:


EFTSL value:0.125
Unit chair:

Morley Muralitharan





Incompatible with:


Contact hours:

24 hours of classes and industry visits


Biopharmaceuticals: Types of commercial biopharmaceuticals, drug development, cytokines, haemopoietic growth factors, growth factors, hormones of therapeutic interest, blood products and therapeutic enzymes, antibodies, vaccines, adjuvants, nucleic acid therapeutics, protein based New Chemical Entities (NCEs), small molecule based New Chemical Entities (NCEs), combinatorial synthesis and computational chemistry in medicinal chemistry; specific drugs such as antibacterials, opium analgesics, etc.; case, pre-clinical development, formulation, Phase 1 Trails, Phase 2 Trials, Phase 3 Trials, regulatory approval, product labeling, marketing and launch, product monitoring and improvement.

Medical Devices: Introduction to medical devices, types (any article, including software, intended to be used by human beings for the prevention, monitoring or treatment of a disease, injury or physiological process – including the control of conception), regulatory aspects of the various types of medical devices, experimental design, device discovery, device engineering, device electronics, device materials, device pre-clinical development, testing, clinical trials, regulatory approval, product labelling, marketing and launch and product monitoring and improvement.

Nutriceuticals: Functional foods, additives, nutrichemicals (eg. Probiotics, unsaturated fatty acids)


Project reports 40%, examination 60%

Unit Fee Information

All Commonwealth Supported Place (CSP), fee paying undergraduate and pre-2016 commencing students

Unit fee information available soon

Return to previous page